AR
Abhinav Reddy Nandigala
About Abhinav Reddy Nandigala
Data last updated:
Abhinav Reddy Nandigala is a Whole-Time Director at Covalent Laboratories Private Limited (since 2023), Director at Virchow Petrochemical Private Limited (since 2024) and Director at Virchow Drugs Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹4,378 Cr; the largest is Covalent Laboratories Private Limited at ₹2,693 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Covalent Laboratories Private Limited U24230TG2002PTC039606 | Whole-Time Director | 19 Oct 2023 | 2002 | ₹2,693 Cr (FY 2025) | Active |
 Virchow Petrochemical Private Limited U23209TG2003PTC041101 | Director | 14 Dec 2024 | 2003 | ₹1,499 Cr (FY 2025) | Active |
| Virchow Drugs Limited U24239TG2004PLC042949 | Director | 16 Dec 2024 | 2004 | ₹185 Cr (FY 2025) | Active |
 Ceph Lifesciences Private Limited U21001TS2025PTC200033 | Additional Director | 23 Jul 2025 | 2025 | Active |
Board colleagues of Abhinav Reddy Nandigala
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhinav Reddy Nandigala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhinav Reddy Nandigala
Abhinav Reddy Nandigala currently holds 4 directorships: Covalent Laboratories Private Limited (Whole-Time Director, since 19 Oct 2023, revenue ₹2,693 Cr (FY 2025)); Virchow Petrochemical Private Limited (Director, since 14 Dec 2024, revenue ₹1,499 Cr (FY 2025)); Virchow Drugs Limited (Director, since 16 Dec 2024, revenue ₹185 Cr (FY 2025)); Ceph Lifesciences Private Limited (Additional Director, since 23 Jul 2025).
Abhinav Reddy Nandigala was first appointed on 19 Oct 2023 as Whole-Time Director at Covalent Laboratories Private Limited. The most recent appointment on record is 23 Jul 2025 at Ceph Lifesciences Private Limited.
The 3 current companies of Abhinav Reddy Nandigala that report revenue have a combined latest revenue of ₹4,378 Cr: Covalent Laboratories Private Limited ₹2,693 Cr (FY 2025); Virchow Petrochemical Private Limited ₹1,499 Cr (FY 2025); Virchow Drugs Limited ₹185 Cr (FY 2025).
The current boards of Abhinav Reddy Nandigala's companies include Maddireddy Vijaykiran (Covalent Laboratories Private Limited), Madireddy Narayana Reddy (Covalent Laboratories Private Limited), Mundla Maha Vishnu (Covalent Laboratories Private Limited), Prasanth Nandigala (Covalent Laboratories Private Limited), Lingareddy Subba Reddy Venkata (Virchow Petrochemical Private Limited), Narayana Reddy Mundla (Virchow Petrochemical Private Limited), among others.